Why some people keep getting UTIs

Urinary tract infections are among the most common bacterial infections, and for many women they aren't a one-time event. A single UTI is uncomfortable enough. A cycle of them is exhausting.

A UTI is classified as recurrent when a person has two or more infections within six months, or three or more within a twelve-month period. These episodes may be caused by the same organism (relapse) or by a new pathogen (reinfection). The distinction matters for treatment planning.

The numbers are striking. About 1 in 3 women will have had at least one UTI by age 24, and over half will have one in their lifetime. Of those, roughly 26% will have another within six months. This isn't a fringe problem. It's one of the most frequent reasons women see a doctor.

Written by Ankitha | Medically reviewed by Dr. Mohan Pandit

Symptoms to watch for

UTI symptoms range from mildly annoying to severely disruptive. Catching them early helps you start treatment before the infection moves up to the kidneys. Common symptoms of lower UTI (cystitis):

• Burning or stinging during urination (dysuria): usually the first and most obvious sign
• Frequent urination: feeling the urge much more often than usual, even when the bladder isn't full
• Urgency: a sudden, strong need to urinate that's hard to delay
• Cloudy, dark, or strong-smelling urine
• Blood in the urine (hematuria): urine may look pink, red, or cola-coloured
• Pelvic pressure or discomfort, often just above the pubic bone
• Low-grade fever or general malaise

If the infection moves to the kidneys (pyelonephritis), expect high fever, chills, flank or back pain, nausea, and vomiting. Kidney infections need urgent care and usually more aggressive antibiotic therapy.

What causes recurrent UTIs

The bacteria behind UTIs

Roughly 80 to 90 percent of UTIs are caused by Escherichia coli (E. coli), a bacterium that normally lives in the gastrointestinal tract. When E. coli migrates from the perianal area to the urethra and bladder, it can stick to the bladder lining and multiply. Other organisms that can cause UTIs include:

• Klebsiella pneumoniae
• Enterococcus faecalis
• Proteus mirabilis
• Staphylococcus saprophyticus (particularly common in younger, sexually active women)
• Pseudomonas aeruginosa (more common in catheter-associated or hospital-acquired UTIs)

Some strains of E. coli have specialized structures called type 1 pili (fimbriae) that let them grip the bladder epithelium firmly. These uropathogenic strains can invade bladder cells and form intracellular bacterial communities shielded from antibiotics and from the immune system. That's part of why some infections seem to come back even after a clean course of treatment.

Reinfection vs relapse

The distinction between reinfection and relapse changes how you treat:

• Reinfection accounts for about 80% of recurrent UTIs. The original infection clears completely, but a new one develops, often with a different bacterial strain. Reinfections typically happen more than two weeks after the prior episode cleared.
• Relapse is the same organism persisting despite treatment and causing symptoms again, usually within two weeks of finishing antibiotics. Relapse can signal an inadequate course, antibiotic resistance, or a structural problem in the urinary tract that harbours bacteria.

Risk factors

Several anatomical, behavioural, hormonal, and medical factors contribute to recurrent UTIs.

Anatomical factors

• Shorter urethra: women have a much shorter urethra than men (about 4 cm vs 20 cm), so bacteria have less distance to travel to reach the bladder.
• Proximity of the urethra to the anus: this makes it easier for fecal bacteria to migrate to the urinary tract.
• Incomplete bladder emptying: leftover urine acts as a growth medium for bacteria. Common causes include pelvic organ prolapse, neurological conditions, and habitual voiding patterns.

Hormonal and life-stage factors

• Menopause and declining estrogen: estrogen supports protective Lactobacillus populations in the vagina and keeps urethral and vaginal tissue healthy. After menopause, vaginal pH rises, Lactobacillus drops, and the tissue thins. All of this raises UTI risk. Postmenopausal women have substantially higher rates of recurrent UTI.
• Pregnancy: hormonal and anatomical changes including ureteral dilation and reduced bladder tone raise UTI risk. Asymptomatic bacteriuria in pregnancy needs treatment because of the risk of pyelonephritis and adverse obstetric outcomes.

Behavioural and lifestyle factors

• Sexual activity: one of the strongest UTI risk factors in premenopausal women. Mechanical pressure during intercourse can introduce bacteria into the urethra.
• Spermicide and diaphragm use: spermicides (including spermicide-coated condoms) disrupt normal vaginal flora and reduce protective Lactobacillus. Diaphragms can compress the urethra and impair bladder emptying.
• Wiping habits: wiping back to front can transfer fecal bacteria toward the urethra.
• Irritating products: scented soaps, douches, bubble baths, and feminine hygiene sprays can irritate the urethra and upset the vaginal microbiome.

Medical factors

• Diabetes: high blood glucose impairs immune function and promotes bacterial growth. Glucose in the urine (glycosuria) is an ideal culture medium.
• Immunosuppression: conditions or medications that weaken the immune system raise the risk of all infections, UTIs included.
• Urinary catheterization: indwelling catheters bypass the body's natural defences and give bacteria a direct route to the bladder.
• Kidney stones or structural abnormalities: these can cause urinary stasis and serve as a nidus for persistent infection.
• History of UTI: a prior UTI is itself one of the strongest predictors of future UTIs, likely a mix of genetic susceptibility, persistent bacterial reservoirs, and ongoing exposure to risk factors.

Diagnosing recurrent UTIs

When recurrent UTIs are suspected, your healthcare provider will typically do four things:

1. Take a thorough history: timing, frequency, and severity of past infections, antibiotic use, sexual activity, contraceptive methods, and menopausal status.
2. Run a urinalysis: a dipstick can quickly flag nitrites, leukocyte esterase, and blood, all of which suggest infection.
3. Order urine culture and sensitivity: this identifies the exact organism and which antibiotics it responds to. Especially important in recurrent UTIs to target therapy and catch resistant organisms.
4. Consider imaging or cystoscopy: when relapse is suspected or symptoms are atypical, ultrasound, CT, or cystoscopy can rule out structural problems, stones, or other pathology.

In Canada, urine culture is covered by provincial health plans when ordered by a physician or nurse practitioner. A mid-stream clean-catch specimen is needed for accurate results.

Prevention strategies

Preventing recurrent UTIs usually means combining behavioural changes, dietary tweaks, and in some cases medical prophylaxis. The strategies below have different levels of evidence behind them.

Behavioural and hygiene measures

• Stay well-hydrated: at least 1.5 to 2 litres of water a day. A 2018 randomized controlled trial in JAMA Internal Medicine found that women who added 1.5 litres of daily water intake had 48% fewer UTI episodes than those who didn't.
• Urinate frequently and don't hold it: regular emptying prevents bacterial build-up.
• Urinate after sex: the evidence is observational rather than randomized, but it's a widely recommended, low-risk habit.
• Wipe front to back: cuts the chance of transferring intestinal bacteria to the urethra.
• Skip scented products near the genitals: unscented soap and water are enough. Avoid douching, which disrupts the protective vaginal microbiome.
• Wear breathable cotton underwear: avoid tight synthetic clothing that traps moisture.
• Review contraception: if you use spermicides or a diaphragm and keep getting UTIs, talk to your provider about alternatives.

Dietary and supplement approaches

• Cranberry products: cranberries contain proanthocyanidins (PACs), compounds that may stop E. coli from sticking to the bladder wall. A 2023 Cochrane review of over 50 trials found cranberry products cut UTI risk by about 25% in women with recurrent infections, with the strongest evidence for capsules or tablets standardized to PAC content. Sugary cranberry juice cocktails are weaker and aren't generally recommended. Aim for at least 36 mg of PACs per day.
• D-mannose: this naturally occurring sugar was once thought to interfere with E. coli adhesion to the bladder. A large 2024 randomized trial in JAMA (n=598) found no significant difference between D-mannose and placebo (51.0% vs 55.7% recurrence). It's available over the counter in Canada and is well tolerated, but the current evidence doesn't support it as effective prevention.
• Probiotics: Lactobacillus-based probiotics (particularly L. rhamnosus and L. reuteri) may help rebuild a healthy vaginal microbiome and crowd out uropathogenic bacteria. Evidence is mixed but promising, and they're safe for most people. Vaginal suppositories may work better than oral formulations.
• Limit bladder irritants: caffeine, alcohol, artificial sweeteners, and highly acidic foods can irritate the bladder lining and worsen symptoms, though they don't directly cause infection.

Medical prophylaxis

When behavioural measures and supplements aren't enough, your provider may recommend one of the following evidence-based options:

• Vaginal estrogen therapy: for peri- and postmenopausal women, topical vaginal estrogen (cream, ring, or tablet) is one of the most effective interventions. The 2025 AUA/CUA/SUFU guideline strongly recommends it for this population. By restoring Lactobacillus and normalizing vaginal pH, vaginal estrogen has been shown in meta-analyses to cut UTI recurrence by around 58%. Systemic absorption is minimal and it's generally considered safe even when systemic hormone therapy isn't an option.
• Low-dose antibiotic prophylaxis: continuous low-dose antibiotics taken daily or three times a week for 6 to 12 months can reduce recurrence by 60 to 95%. Common regimens: nitrofurantoin 50 mg nightly (50 mg is preferred over 100 mg: equivalent efficacy, fewer side effects), trimethoprim-sulfamethoxazole half a single-strength tablet nightly, or fosfomycin 3 g every 10 days. Prophylaxis is usually held in reserve for women who haven't responded to non-antibiotic strategies, given concerns about resistance, side effects, and flora disruption.
• Post-coital antibiotic prophylaxis: for women whose UTIs clearly track with sex, a single dose (nitrofurantoin 50-100 mg or TMP-SMX single strength) within two hours after intercourse can be highly effective with much less total antibiotic exposure than daily prophylaxis.
• Methenamine hippurate: a urinary antiseptic that converts to formaldehyde in acidic urine, killing bacteria without driving resistance. The 2022 UK ALTAR randomized trial found methenamine hippurate (1 g twice daily) non-inferior to low-dose antibiotics for preventing recurrent UTI. A good option for women who want to avoid prophylactic antibiotics. Available in Canada and well tolerated.

Treating acute UTI episodes

When a recurrent UTI does flare, prompt treatment with the right antibiotic is what relieves symptoms and prevents the infection from climbing to the kidneys.

First-line antibiotics in Canada

Canadian guidelines for uncomplicated lower UTI (acute cystitis) in adult women recommend:

• Nitrofurantoin (Macrobid): 100 mg twice daily for 5 days. Achieves high concentrations in the urine and has held low resistance rates for decades. Avoid in significant renal impairment (eGFR below 30 mL/min).
• Trimethoprim-sulfamethoxazole (TMP-SMX, Septra): one double-strength tablet (160/800 mg) twice daily for 3 days. Effective and well-studied, but resistance is rising in some regions. Use empirically only when local resistance is below 20%.
• Fosfomycin (Monurol): a single 3 g oral dose. Convenient because of the single-dose regimen, though it may be slightly less effective than multi-day therapies for some patients. Good activity against most uropathogenic E. coli, including many multidrug-resistant strains.

Second-line and alternative agents

• Pivmecillinam (Selexid): 200 mg three times daily for 3 to 7 days, or 400 mg twice daily for 3 to 7 days. Widely used in Scandinavia and available in Canada as Selexid (200 mg tablets). Good activity against gram-negative uropathogens and low resistance rates.
• Fluoroquinolones (ciprofloxacin, levofloxacin): reserved for complicated UTIs or when first-line agents aren't suitable. Serious adverse effects include tendon rupture, peripheral neuropathy, and aortic dissection, and resistance is rising. Health Canada has issued safety warnings.
• Beta-lactams (amoxicillin-clavulanate, cephalosporins): used when first-line agents are contraindicated. Generally less effective for uncomplicated UTI and harder on gut flora.

For recurrent UTIs, urine culture results that guide antibiotic choice are especially valuable. Your provider can match the antibiotic to the organism and its susceptibility pattern, which improves cure rates and reduces unnecessary broad-spectrum use.

Self-start (patient-initiated) therapy

For selected patients with a well-established pattern of recurrent UTI, providers may prescribe a course of antibiotics to keep at home. The patient starts treatment at the first sign of symptoms, collects a urine sample for culture, and contacts the provider if symptoms don't improve within 48 hours. This cuts treatment delay and unnecessary clinic visits while keeping medical oversight in place.

When to see a doctor

Mild UTI symptoms may be familiar territory for women with recurrent infections, but some situations need prompt evaluation:

• Fever above 38.0 °C, chills, or flank pain: suggests pyelonephritis (kidney infection), which needs more aggressive treatment and sometimes IV antibiotics.
• Blood in the urine, especially if visible or persistent. Small amounts are common with cystitis, but significant or repeated hematuria warrants investigation.
• Symptoms that don't improve within 48 hours of starting antibiotics: could mean resistance or a different diagnosis.
• UTI symptoms in pregnancy: carries risks for both mother and baby and always needs prompt treatment.
• Recurrent infections (two or more in six months): time to work out a structured evaluation and prevention plan with a provider.
• UTI symptoms in men, children, or anyone with urinary tract abnormalities: these are considered complicated UTIs and need further work-up.

Research on the horizon

Several lines of research are reshaping how recurrent UTI may be prevented and treated:

• Vaccines: MV140 (Uromune) is a sublingual bacterial vaccine that exposes the immune system to heat-inactivated uropathogenic bacteria. A 9-year follow-up presented at EAU 2024 found 54% of participants remained UTI-free. MV140 is approved in about 20 countries. The Health Canada submission was withdrawn before a final decision, but the vaccine is accessible through a Special Access Program. Other E. coli surface protein vaccine candidates are in clinical trials.
• Bacteriophage therapy: phages are viruses that target and destroy bacteria. They offer the prospect of highly targeted treatment without the collateral damage of broad-spectrum antibiotics. Early-phase trials in UTI are underway.
• Fecal microbiota transplantation (FMT): researchers are exploring whether restoring healthy gut flora via FMT can reduce colonization with uropathogenic E. coli. Still early-stage work.
• Immunomodulatory agents: OM-89 (Uro-Vaxom) is an oral immunostimulant containing E. coli extracts. Used in parts of Europe and Asia for UTI prevention, with modest benefit in several trials. Not widely available in Canada yet.
• Intravesical therapies: bladder instillations with hyaluronic acid and chondroitin sulfate aim to repair the glycosaminoglycan (GAG) layer that lines the bladder and shields it from bacterial adhesion. Some studies show meaningful reductions in recurrence, particularly in postmenopausal women.

Frequently Asked Questions

1. How many UTIs per year is considered "recurrent"?
   Answer: Recurrent UTIs are generally defined as two or more infections within six months, or three or more within a twelve-month period. If you are experiencing infections at this frequency, you should discuss a prevention plan with your healthcare provider.
2. Can recurrent UTIs cause permanent kidney damage?
   Answer: Uncomplicated lower UTIs (cystitis) do not typically cause kidney damage. However, repeated kidney infections (pyelonephritis) that go untreated or are inadequately treated can potentially lead to scarring and impaired kidney function over time. This is why prompt and complete treatment of all UTIs is important.
3. Are UTIs sexually transmitted?
   Answer: UTIs are not considered sexually transmitted infections. However, sexual activity is a significant risk factor for UTIs because intercourse can introduce bacteria into the urethra. Urinating after intercourse and staying well-hydrated may help reduce this risk.
4. Can men get recurrent UTIs?
   Answer: Yes, though UTIs are less common in men due to their longer urethra. When men do experience recurrent UTIs, it often suggests an underlying condition such as an enlarged prostate, kidney stones, or a structural abnormality, and warrants thorough investigation.
5. Does cranberry juice really prevent UTIs?
   Answer: Cranberry products contain proanthocyanidins that may prevent bacteria from adhering to the bladder wall. A 2023 Cochrane review found modest benefit, particularly with cranberry capsules or tablets. However, sweetened cranberry juice cocktails are not recommended due to high sugar content and lower PAC concentration. If you choose to use cranberry, look for standardized supplements containing at least 36 mg of PACs daily.
6. Is it safe to take low-dose antibiotics for months to prevent UTIs?
   Answer: Long-term low-dose antibiotic prophylaxis (typically 6 to 12 months) is a well-established strategy for women with frequent recurrences and is generally safe. However, it does carry risks including yeast infections, gastrointestinal side effects, and the development of antibiotic-resistant bacteria. Non-antibiotic alternatives such as methenamine hippurate and vaginal estrogen (for postmenopausal women) should be considered first.
7. Can UTIs be diagnosed and treated through telemedicine?
   Answer: Yes. For straightforward, uncomplicated recurrent UTIs in women with a well-established pattern, telemedicine consultations can be an efficient way to obtain assessment and treatment. Your provider may request a urine culture to confirm the diagnosis and guide antibiotic selection.
8. Why do my UTIs keep coming back even after I finish antibiotics?
   Answer: There are several possible reasons. The original bacteria may have formed intracellular reservoirs in the bladder lining that are not fully cleared by antibiotics. You may also be experiencing reinfection with new bacteria due to ongoing risk factors. In some cases, the antibiotic prescribed may not have been effective against the specific organism. Urine culture with sensitivity testing can help identify the right antibiotic, and a comprehensive prevention plan can address modifiable risk factors.

How TeleTest fits in

If you're dealing with recurrent UTIs, you don't have to wait weeks for a clinic appointment. TeleTest consultations are confidential and run through secure messaging. A licensed Canadian clinician can assess symptoms, order a urine culture, prescribe antibiotics, and put together a prevention plan tailored to your history.

For an acute flare or a longer conversation about prevention, start a consultation.

Disclaimer: This blog post is intended for educational purposes only and should not be taken as medical advice. Always consult your healthcare provider for personal health concerns.

---